Literature DB >> 28587924

PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.

Mamta Verma1, Ramya Chandar M Charles2, Baskar Chakrapani1, Mohane Selvaraj Coumar2, Gayathri Govindaraju3, Arumugam Rajavelu3, Sreenivas Chavali4, Arunkumar Dhayalan5.   

Abstract

Protein arginine methyltransferase 7 (PRMT7) catalyzes the introduction of monomethylation marks at the arginine residues of substrate proteins. PRMT7 plays important roles in the regulation of gene expression, splicing, DNA damage, paternal imprinting, cancer and metastasis. However, little is known about the interaction partners of PRMT7. To address this, we performed yeast two-hybrid screening of PRMT7 and identified argininosuccinate synthetase (ASS1) as a potential interaction partner of PRMT7. We confirmed that PRMT7 directly interacts with ASS1 using pull-down studies. ASS1 catalyzes the rate-limiting step of arginine synthesis in urea cycle and citrulline-nitric oxide cycle. We mapped the interface of PRMT7-ASS1 complex through computational approaches and validated the predicted interface in vivo by site-directed mutagenesis. Evolutionary analysis revealed that the ASS1 residues important for PRMT7-ASS1 interaction have co-evolved with PRMT7. We showed that ASS1 mutations linked to type I citrullinemia disrupt the ASS1-PRMT7 interaction, which might explain the molecular pathogenesis of the disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  arginine biosynthesis; argininosuccinate synthetase; co-evolution; protein arginine methyltransferase; urea cycle

Mesh:

Substances:

Year:  2017        PMID: 28587924     DOI: 10.1016/j.jmb.2017.05.026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  The phenotype of adult versus pediatric patients with inborn errors of metabolism.

Authors:  Jean-Marie Saudubray; Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2018-06-06       Impact factor: 4.982

2.  Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy.

Authors:  Lulu Jiang; Weiwei Lin; Cheng Zhang; Peter E A Ash; Mamta Verma; Julian Kwan; Emily van Vliet; Zhuo Yang; Anna Lourdes Cruz; Samantha Boudeau; Brandon F Maziuk; Shuwen Lei; Jaehyup Song; Victor E Alvarez; Stacy Hovde; Jose F Abisambra; Min-Hao Kuo; Nicholas Kanaan; Melissa E Murray; John F Crary; Jian Zhao; Ji-Xin Cheng; Leonard Petrucelli; Hu Li; Andrew Emili; Benjamin Wolozin
Journal:  Mol Cell       Date:  2021-08-27       Impact factor: 19.328

3.  PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling.

Authors:  Mamta Verma; Mohd Imran K Khan; Rajashekar Varma Kadumuri; Baskar Chakrapani; Sharad Awasthi; Arun Mahesh; Gayathri Govindaraju; Pavithra L Chavali; Arumugam Rajavelu; Sreenivas Chavali; Arunkumar Dhayalan
Journal:  Commun Biol       Date:  2021-01-25

4.  Identification of Novel Mutations in Chinese Infants With Citrullinemia.

Authors:  Zhi Cheng; Xiwen He; Fa Zou; Zhen-E Xu; Chun Li; Hao Liu; Jingkun Miao
Journal:  Front Genet       Date:  2022-03-03       Impact factor: 4.599

5.  Hypoxia-induced TGF-β-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer.

Authors:  Neha Ahuja; Cheemala Ashok; Subhashis Natua; Deepak Pant; Anna Cherian; Madhura R Pandkar; Pooja Yadav; Narayanan S S Vishnu; Jharna Mishra; Atul Samaiya; Sanjeev Shukla
Journal:  NAR Cancer       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.